ImpediMed Future Growth
Future criteria checks 2/6
ImpediMed is forecast to grow earnings and revenue by 38.1% and 39.8% per annum respectively. EPS is expected to grow by 44% per annum. Return on equity is forecast to be -11.9% in 3 years.
Key information
38.1%
Earnings growth rate
44.0%
EPS growth rate
Medical Equipment earnings growth | 16.3% |
Revenue growth rate | 39.8% |
Future return on equity | -11.9% |
Analyst coverage | Low |
Last updated | 01 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 32 | -5 | -1 | 3 | 1 |
6/30/2025 | 19 | -14 | -17 | -13 | 2 |
6/30/2024 | 11 | -21 | -23 | -18 | 2 |
12/31/2023 | 10 | -19 | -18 | -13 | N/A |
9/30/2023 | 11 | -20 | -21 | -15 | N/A |
6/30/2023 | 11 | -21 | -24 | -18 | N/A |
3/31/2023 | 11 | -21 | -25 | -20 | N/A |
12/31/2022 | 11 | -22 | -27 | -22 | N/A |
9/30/2022 | 11 | -21 | -24 | -19 | N/A |
6/30/2022 | 11 | -20 | -21 | -16 | N/A |
3/31/2022 | 10 | -20 | -19 | -14 | N/A |
12/31/2021 | 10 | -19 | -17 | -13 | N/A |
9/30/2021 | 9 | -20 | -16 | -13 | N/A |
6/30/2021 | 8 | -21 | -16 | -13 | N/A |
3/31/2021 | 7 | -20 | -17 | -15 | N/A |
12/31/2020 | 6 | -19 | -18 | -16 | N/A |
9/30/2020 | 6 | -20 | -20 | -18 | N/A |
6/30/2020 | 6 | -21 | -21 | -19 | N/A |
12/31/2019 | 5 | -25 | -22 | -20 | N/A |
9/30/2019 | 5 | -24 | -22 | -20 | N/A |
6/30/2019 | 4 | -24 | -22 | -20 | N/A |
12/31/2018 | 4 | -25 | -23 | -21 | N/A |
9/30/2018 | 3 | -26 | -24 | -22 | N/A |
6/30/2018 | 3 | -27 | -25 | -23 | N/A |
3/31/2018 | 4 | -28 | N/A | N/A | N/A |
12/31/2017 | 4 | -28 | -26 | -26 | N/A |
9/30/2017 | 5 | -28 | N/A | -26 | N/A |
6/30/2017 | 6 | -28 | N/A | -26 | N/A |
3/31/2017 | 6 | -28 | N/A | -25 | N/A |
12/31/2016 | 6 | -29 | N/A | -25 | N/A |
9/30/2016 | 6 | -27 | N/A | -24 | N/A |
6/30/2016 | 6 | -26 | N/A | -22 | N/A |
3/31/2016 | 6 | -23 | N/A | -19 | N/A |
12/31/2015 | 5 | -20 | N/A | -16 | N/A |
9/30/2015 | 5 | -17 | N/A | -13 | N/A |
6/30/2015 | 5 | -15 | N/A | -11 | N/A |
3/31/2015 | 4 | -13 | N/A | -9 | N/A |
12/31/2014 | 4 | -10 | N/A | -8 | N/A |
9/30/2014 | 4 | -9 | N/A | -7 | N/A |
6/30/2014 | 4 | -8 | N/A | -7 | N/A |
3/31/2014 | 3 | -7 | N/A | -6 | N/A |
12/31/2013 | 3 | -7 | N/A | -6 | N/A |
9/30/2013 | 3 | -8 | N/A | -7 | N/A |
6/30/2013 | 3 | -8 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IPDQ.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IPDQ.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IPDQ.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IPDQ.F's revenue (39.8% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: IPDQ.F's revenue (39.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IPDQ.F is forecast to be unprofitable in 3 years.